AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has announced the relocation of its Singapore office to the NUHS Center for Innovation in Healthcare (CIH) on January 1st, 2023. With this relocation, AIM will further advance its collaborative research activities with Singapore’s National University Health System (NUHS) and National University Hospital (NUH). AIM plans to expand its activities in the Southeast Asia region through its Singapore hub.
■Background of Establishment
AIM established a Singapore subsidiary in July 2022 and has been setting the stage for the global adoption of endoscopic AI. In April 2021, AIM signed a joint research agreement with NUH and has since been conducting joint research on endoscopic AI.
By relocating to an office within CIH (a division of NUHS), AIM will fortify its framework for joint research and business development in the Southeast Asia region. AIM will also exhibit its endoscopic AI within CIH’s Innovation Showroom to expand awareness and understanding of endoscopic AI. This exhibit will allow medical professionals in the Asian region to experience endoscopic AI.
■About the National University Health System (NUHS) and the NUHS Centre for Innovation in Healthcare (CIH)
The National University Health System (NUHS) is one of Singapore's three public healthcare clusters and an integrated Academic Health System and Regional Health System that delivers value-driven, innovative, and sustainable healthcare in Singapore. As a Regional Health System, NUHS works in close collaboration with community hospitals, general practitioners, family medicine clinics, nursing homes, and other community partners to provide integrated care to the community.
NUHS works with 13 hospitals, polyclinics, specialist centers, medical centers, and medical academic and research institutions, led by the National University Hospital (NUH), one of Singapore's leading public integrated healthcare facilities. NUHS also works on training the next generation of healthcare professionals to solve healthcare problems in Singapore.
The NUHS Centre for Innovation in Healthcare (CIH) is one of six NUHS Centres of Excellence (CoEs) location at Alexandra Hospital. It aims to develop and implement new models of care, incorporating smart technologies as well as innovations in research and training to meet present and future national healthcare needs. CIH actively facilitates inter-disciplinary research, innovation and enterprise across science, engineering and other disciplines and provides a one-stop ecosystem to testbed solutions including new devices, technologies and work processes, at scale.
■General Information about the Singapore branch
Name： AI Medical Service Asia Pte. Ltd.
Date of establishment： Jul. 8, 2022
New address： 378 Alexandra Rd, Block 29 Level 1 CIH Co-Working Space, Singapore 159964
■About AI Medical Service Inc.
AI Medical Service (AIM) is a Tokyo-based med-tech company established with the mission to “Save Lives All Over the World.” Japan leads the world in endoscopic diagnosis and treatment, providing firms and researchers with access to large amounts of high-quality data. AIM is the leading player in the field of endoscopic AI, engaging in joint research with more than 100 medical institutions. By bringing endoscopic AI to the real-world clinical setting as soon as possible, AIM aims to reduce the number of missed cancer diagnoses and save lives around the world.
■About CEO of AI Medical Service Inc., Dr. Tada
Tomohiro TADA, M.D., Ph.D.
Dr. Tomohiro TADA is the CEO of AI Medical Service Inc., the chairperson of Tada Tomohiro The Institute of Gastroenterology & Proctology, and Visiting Lecturer, Department of Surgical Oncology, Graduate School of Medicine, the University of Tokyo Hospital.
Dr. TADA received his M.D. of school of medicine in 1996 and Ph.D. of department of surgery in 2005 from the University of Tokyo. He trained in Colorectal Surgery at the University of Tokyo Hospital.
■Related Press Release
・Apr. 27, 2021 “AIM and Singapore’s National University Hospital Sign Joint Research Agreement on Endoscopic AI 〜The research will be focused on testing the utility of Endoscopic AI in Singapore〜”
・Jul. 11, 2022 “AIM Establishes local subsidiary in Singapore 〜Accelerating the overseas expansion of “Endoscopic AI” by establishing a second overseas branch〜”
Company Profile ――――――――――――――――――――――――――――――
Company： AI Medical Service Inc.
Address： Hareza Tower 11F, 1-18-1 Higashiikebukuro, Toshima-ku, Tokyo 170-0013, Japan
CEO： Tomohiro Tada
Founding： September 1, 2017
Business： Development of Endoscopic AI
（Last edited on January 18, 2023）
Feel free to contact us using the form below regarding joint research,
media coverage, business partnerships, or related opportunities.